Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

Last updated: October 14, 2024
Sponsor: Meir Hospital, Kfar Saba, Israel
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemorrhage

Treatment

femoral neck CRIF

Clinical Study ID

NCT06644976
mmc000723
  • Ages > 18
  • All Genders

Study Summary

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

Eligibility Criteria

Inclusion

Inclusion Criteria:

above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery

Exclusion

  • Exclusion Criteria:

  • under 18 y.o

  • anti platelet therapy (aspirin is not included)

  • creatinine clearance under 50

  • active anti cancer therapy

  • ITP patients

  • non capable of making inform consent

  • patients which decide not to proceed with the expeirment

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: femoral neck CRIF
Phase:
Study Start date:
August 20, 2024
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Meir Hospital

    Kfar Saba, 4428164
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.